|
2022 Journal Article Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patientsLing, Lowell, Mui, Oliver Oi Yat, Laupland, Kevin B., Lefrant, Jean-Yves, Roberts, Jason A., Gopalan, Pragasan Dean, Lipman, Jeffrey, Joynt, Gavin M., Stelfox, Tom, Niven, Daniel, Paramalingam, Rameiya, Vonderhaar, Derek, Freebairn, Ross, Ling, Lowell, Leung, Patricia, Gopalan, Dean, Lefrant, Jean Yves, Lloret, Sophie, Elotmani, Loubna, Fourie, Cheryl, Saba, Renee, Carlisle, Dougal and Edwards, Felicity (2022). Scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients. Journal of Intensive Care, 10 (1) 44, 1-10. doi: 10.1186/s40560-022-00633-4 |
|
2022 Journal Article The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foeTong, Steven Y. C., Mora, Jocelyn, Bowen, Asha C., Cheng, Matthew P., Daneman, Nick, Goodman, Anna L., Heriot, George S., Lee, Todd C., Lewis, Roger J., Lye, David C., Mahar, Robert K., Marsh, Julie, McGlothlin, Anna, McQuilten, Zoe, Morpeth, Susan C., Paterson, David L., Price, David J., Roberts, Jason A., Robinson, J Owen, van Hal, Sebastiaan J., Walls, Genevieve, Webb, Steve A., Whiteway, Lyn, Yahav, Dafna and Davis, Joshua S. (2022). The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe. Clinical Infectious Diseases, 75 (11), 2027-2034. doi: 10.1093/cid/ciac476 |
|
2022 Conference Publication Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection modelAvent, Minyon, Mccarthy, Kate, Sime, Fekade, Naickera, Saiyuri, Heffernan, Aaron, Wallis, Steven, Paterson, David and Roberts, Jason A (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA, Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier . doi: 10.1016/s2213-7165(22)00314-9 |
|
2022 Conference Publication Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bloodstream infections in Central AustraliaLangham, Freya, Tsai, Danny, Camilleri, Shayne, Forde, Brian, Harris, Patrick, Roberts, Jason A. and Chiong, Fabian (2022). Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bloodstream infections in Central Australia. 32nd International Congress of Antimicrobial Chemotherapy (ICC), Perth, WA Australia, 27-30 November 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s2213-7165(22)00286-7 |
|
2022 Journal Article Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 TrialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial. Clinical Drug Investigation, 43 (1), 35-35. doi: 10.1007/s40261-022-01224-9 |
|
2022 Conference Publication Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19McQuilten, Zoe, Venkatesh, Balasubramanian, Jha, Vivekanand, Roberts, Jason, Morpeth, Susan, Totterdell, James, McPhee, Grace, Abraham, John, Bam, Niraj, Bandara, Methma, Bangi, Ashpak, Barina, Lauren, Basnet, Bhupendra, Bhally, Hasan, Bhusal, Khemr, Bogati, Umesh, Bowen, Asha, Burke, Andrew, Christopher, Devasahayam, Chunilal, Sanjeev, Cochrane, Belinda, Curnow, Jennifer, Reddy, Varaprasad Babu Dara, Das, Santa, Dhungana, Ashesh, Di Tanna, Gian Luca, Dotel, Ravindra, DSouza, Hyjel, Dummer, Jack ... Tong, Steven Y. C. (2022). Anticoagulation and antiplatelet strategies in non-critically ill patients with Covid-19. 64th Annual Meeting and Exposition of the American Society of Hematology (ASH), New Orleans, LA United States, 10-13 December 2022. Amsterdam, Netherlands: Elsevier. doi: 10.1182/blood-2022-168448 |
|
2022 Journal Article Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trialKong, Fabian Y. S., Unemo, Magnus, Lim, Shueh H., Latch, Ngaire, Williamson, Deborah A., Roberts, Jason A., Wallis, Steven C., Parker, Suzanne L., Landersdorfer, Cornelia B., Yap, Tami, Fairley, Christopher K., Chow, Eric P F, Lewis, David A., Hammoud, Mohamed A. and Hocking, Jane S. (2022). Optimisation of treatments for oral Neisseria gonorrhoeae infection: Pharmacokinetics Study (STI-PK project) - study protocol for non-randomised clinical trial. BMJ open, 12 (11) e064782, 1-8. doi: 10.1136/bmjopen-2022-064782 |
|
2022 Journal Article Evaluation of fosfomycin-sulbactam combination therapy against carbapenem-resistant Acinetobacter baumannii isolates in a hollow-fibre infection modelMohd Sazlly Lim, Sazlyna, Heffernan, Aaron, Naicker, Saiyuri, Wallis, Steven, Roberts, Jason A. and Sime, Fekade Bruck (2022). Evaluation of fosfomycin-sulbactam combination therapy against carbapenem-resistant Acinetobacter baumannii isolates in a hollow-fibre infection model. Antibiotics, 11 (11) 1578, 1-11. doi: 10.3390/antibiotics11111578 |
|
2022 Journal Article Closed-loop control of continuous piperacillin delivery: an in silico studyHerrero, Pau, Wilson, Richard C., Armiger, Ryan, Roberts, Jason A., Holmes, Alison, Georgiou, Pantelis and Rawson, Timothy M. (2022). Closed-loop control of continuous piperacillin delivery: an in silico study. Frontiers in Bioengineering and Biotechnology, 10 1015389, 1-10. doi: 10.3389/fbioe.2022.1015389 |
|
2022 Journal Article Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trialLegg, Amy, Meagher, Niamh, Johnson, Sandra A., Roberts, Matthew A., Cass, Alan, Scheetz, Marc H., Davies, Jane, Roberts, Jason A., Davis, Joshua S. and Tong, Steven Y. C. (2022). Risk factors for nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteraemia: a post hoc analysis of the CAMERA2 trial. Clinical Drug Investigation, 43 (1), 23-33. doi: 10.1007/s40261-022-01204-z |
|
2022 Journal Article Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patientsTruong, Anh Quan, Dao, Xuan Co, Vu, Dinh Hoa, Nguyen, Hoang Anh, Do, Thi Hong Gam, Tran, Nhan Thang, Tran, Nhat Minh, Vu, Ngan Binh, Pham, Hong Nhung, Bui, Van Cuong, Trinh, The Anh, Dang, Quoc Tuan, Nguyen, Gia Binh, Lipman, Jeffrey, Cotta, Menino O. and Roberts, Jason A. (2022). Optimizing meropenem in highly resistant Klebsiella pneumoniae environments: population pharmacokinetics and dosing simulations in critically ill patients. Antimicrobial Agents and Chemotherapy, 66 (11) e0032122, 1-11. doi: 10.1128/aac.00321-22 |
|
2022 Conference Publication Is creatinine and tacrolimus measurement through vams microsampling the future for adault kidney transplant patients?Scuderi, Carla, Parker, Suzanne, Jacks, Margaret, John, George, Mcwhinney, Brett, Ungerer, Jacobus, Mallett, Andrew, Healy, Helen, Roberts, Jason and Staatz, Christine (2022). Is creatinine and tacrolimus measurement through vams microsampling the future for adault kidney transplant patients?. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Australia, 17–19 October 2022. Richmond, VIC, Australia: John Wiley & Sons. |
|
2022 Conference Publication Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?Scuderi, Carla, Parker, Suzanne, Jacks, Margaret, John, George, McWhinney, Brett, Ungerer, Jacobus, Mallett, Andrew, Healy, Helen, Roberts, Jason and Staatz, Christine (2022). Can microsampling methods replace venepuncture for simultaneous therapeutic drug monitoring of tacrolimus, mycophenolic acid and prednisolone concentrations in adult kidney transplant patients?. 57th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN), Sydney, NSW Australia, 17-19 October 2022. Richmond, VIC Australia: John Wiley & Sons. |
|
2022 Conference Publication Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C. E. (2022). Is creatine and tacrolimus measurement through VAMS microsampling the future for adult kidney transplant patients?. Australian and New Zealand Society of Nephrology meeting, Sydney, NSW Australia, October 2022. |
|
2022 Journal Article A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsBlaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381, 1-16. doi: 10.1126/scitranslmed.abj2381 |
|
2022 Journal Article A lipoglycopeptide antibiotic for Gram-positive biofilm-related infectionsBlaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381. doi: 10.1126/scitranslmed.abj238 |
|
2022 Book Chapter PharmacologyKirk, Christa Jefferis, Abdul-Aziz, Mohd H., Roberts, Jason A., Valencia, Eleonore, Watt, Kevin, MacLaren, Graeme and Shekar, Kiran (2022). Pharmacology. Extracorporeal life support: The ELSO red book. (pp. 643-654) edited by Graeme Maclaren, Daniel Brodie, Roberto Lorusso, Giles Peek, Ravi Thiagarajan and Leen Vercaemst. Ann Arbor, MI, United States: Extracorporeal Life Support Organization. |
|
2022 Journal Article Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programsJager, Nynke G. L., Chai, Ming G., van Hest, Reiner M., Lipman, Jeffrey, Roberts, Jason A. and Cotta, Menino O. (2022). Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programs. Clinical Microbiology and Infection, 28 (9) 1211, 1211-1224. doi: 10.1016/j.cmi.2022.03.041 |
|
2022 Journal Article Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative reviewHernández-Mitre, María Patricia, Tong, Steven Y. C., Denholm, Justin T., Dore, Gregory J., Bowen, Asha C., Lewin, Sharon R., Venkatesh, Balasubramanian, Hills, Thomas E., McQuilten, Zoe, Paterson, David L., Morpeth, Susan C. and Roberts, Jason A. (2022). Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative review. Clinical Pharmacokinetics, 61 (10), 1331-1343. doi: 10.1007/s40262-022-01170-x |
|
2022 Journal Article Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolatesSumi, Chandra Datta, Heffernan, Aaron J., Naicker, Saiyuri, Cottrell, Kyra, Wallis, Steven C., Lipman, Jeffrey, Harris, Patrick N. A., Sime, Fekade B. and Roberts, Jason A. (2022). Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates. Journal of Antimicrobial Chemotherapy, 77 (11), 3026-3034. doi: 10.1093/jac/dkac273 |
